Press Release
Category Added in a WPeMatico Campaign
-
IMPRESS INDIVIDUAL LASH KIT SELECTED AS A GOOD HOUSEKEEPING 2026 BEAUTY AWARDS WINNER
NEW YORK, April 14, 2026 /PRNewswire/ — imPRESS Lashes announced that the Individual Lash Kit was named a winner in…
Read More » -
Accuity Names Cindy Klain Chief Product and Strategy Officer to Advance Innovation and Growth
Healthcare technology leader brings leadership from Optum, Change Healthcare, and GE Healthcare to support Accuity’s next phase of expansion. MOUNT…
Read More » -
Testek Solutions Introduces ADAS 2.0: The Next Generation of Automated Aircraft Hydraulic Component Testing
New Automatic Data Acquisition System delivers faster testing, greater flexibility, and a seamless upgrade path for modern aircraft testing needs…
Read More » -
Lantern Partners AI Rebrands as Lantern, Expanding Its Vision and Reach
Lantern Illuminates Path to Scalable Growth NEW YORK, April 14, 2026 /PRNewswire/ — Lantern Partners AI today announced its rebranding to…
Read More » -
Lantern Partners AI Rebrands as Lantern, Expanding Its Vision and Reach
Lantern Illuminates Path to Scalable Growth NEW YORK, April 14, 2026 /PRNewswire/ — Lantern Partners AI today announced its rebranding to…
Read More » -
DataStrike Promotes Corey Beck to Vice President of Service Delivery
PITTSBURGH, April 14, 2026 /PRNewswire/ — DataStrike, a leader in 100 percent onshore database, cloud, and business intelligence managed services,…
Read More » -
DataStrike Promotes Corey Beck to Vice President of Service Delivery
PITTSBURGH, April 14, 2026 /PRNewswire/ — DataStrike, a leader in 100 percent onshore database, cloud, and business intelligence managed services,…
Read More » -
GlycoNex Receives PMDA Approval in Japan to Initiate First-in-Human Phase 1 Trial of GNX1021 in Gastrointestinal Cancers
GNX1021 is a glycan-targeting antibody-drug conjugate designed to address tumor heterogeneity in gastrointestinal cancers NEW TAIPEI CITY, Taiwan, April 14,…
Read More » -
GlycoNex Receives PMDA Approval in Japan to Initiate First-in-Human Phase 1 Trial of GNX1021 in Gastrointestinal Cancers
GNX1021 is a glycan-targeting antibody-drug conjugate designed to address tumor heterogeneity in gastrointestinal cancers NEW TAIPEI CITY, Taiwan, April 14,…
Read More »
